申请人:Eli Lilly and Company
公开号:US05352690A1
公开(公告)日:1994-10-04
This invention provides 1,2,4-trioxygenated benzene derivatives which are leukotriene B.sub.4 antagonists, formulations of those derivatives, and a method of using those derivatives for the treatment of conditions characterized by an excessive release of leukotrienes.
这项发明提供了1,2,4-三氧化苯衍生物,这些衍生物是白三烯B.sub.4拮抗剂,以及这些衍生物的配方,以及使用这些衍生物治疗由白三烯过度释放引起的疾病的方法。